The principle basis for testing biologicals targeting human CD47 using xenograft tumor models revolves around the fact that the polymorphic SIRPα in NOD mice interacts with human CD47, supporting the growth of xenografts38,39. This evidence concerns the gene SIRPA and neoplasm.